Tech Company Financing Transactions
OrthoCon Funding Round
Private investors participated in a $25 million Series B venture round for OrthoCon. The round closed on 4/9/2009.
Transaction Overview
Company Name
Announced On
4/9/2009
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1 Bridge Street 121
Irvington, NY 10533
USA
Irvington, NY 10533
USA
Phone
Website
Email Address
Overview
ORTHOCON is a privately held, specialty pharmaceutical and medical device company focused on the development of new and innovative products for the orthopaedic and spine surgery markets.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Pacifico
Chief Scientific Officer
Richard Kronenthal
VP - Product Management
David Knaack
VP - Regulatory Affairs
Rosemary Harry
Browse more venture capital transactions:
Prev: 4/9/2009: Piedmont Pharmaceuticals venture capital transaction
Next: 4/10/2009: ScanScout venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs